Action of free and polymer carrier encapsulated doxorubicin towards HCT116 cells of human colorectal carcinoma
Development of novel nanoscale functionalized carriers is nowadays one of the most urgent problems in cancer treatment. The aim of our study was to compare the antineoplastic effect of free doxorubicin and its complex with a nanoscale polymeric carrier towards HTC116 colorectal carcinoma cells. It...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry
2013-04-01
|
| Series: | The Ukrainian Biochemical Journal |
| Subjects: | |
| Online Access: | http://ukrbiochemjournal.org/wp-content/uploads/2015/10/Senkiv_2_13.pdf |
| _version_ | 1797668821197127680 |
|---|---|
| author | Yu. V. Senkiv P. Heffeter A. O. Riabtseva N. M. Boiko O. S. Zaichenko N. Ye. Mitina W. Berger R. S. Stoika |
| author_facet | Yu. V. Senkiv P. Heffeter A. O. Riabtseva N. M. Boiko O. S. Zaichenko N. Ye. Mitina W. Berger R. S. Stoika |
| author_sort | Yu. V. Senkiv |
| collection | DOAJ |
| description | Development of novel nanoscale functionalized carriers is nowadays one of the most urgent problems in cancer treatment. The aim of our study was to compare the antineoplastic effect of free doxorubicin and its complex with a nanoscale polymeric carrier towards HTC116 colorectal carcinoma cells. It was established that application of the complex of poly(5-tret-butylperoxy)-5-methyl-1-hexene-3-in-co-glycydyl metacrylat)-graft-polyethyleneglycol (poly(VEP-GMA-PEG)-graft-PEG), where VEP – 5-tret-butylperoxy)-5-methyl-1-hexene-3-in; GMA – glycydyl metacrylat; graft-PEG – graft-polyethyleneglycol accordingly, functionalized with phosphatidylcholine for doxorubicin delivery increased 10 times the efficiency of cytotoxic action of this drug, as compared wich such efficiency in case of the action of free doxorubicin. The encapsulated form of doxorubicin caused more intensive cleavage of the reparation enzyme PARP and longer delay in G2/M cell cycle arrest, compared to such effects of free doxorubicin. The developed carrier itself is non-toxic to the used mammalian cells and does not cause impairment in their cell cycle. A deletion in both alleles of p53 gene did not affect the antineoplastic action of doxorubicin that was immobilized on the nanoscale carrier. Thus, p53-dependent signaling pathways are not involved in the cytotoxic action of doxorubicin-carrier complex. It is suggested that novel nanoscale polymeric carrier poly(VEP-GMA-PEG)-graft-PEG functionalized with phosphatidylcholine could be a promising carrier for targeted delivery of anticancer drugs. |
| first_indexed | 2024-03-11T20:34:05Z |
| format | Article |
| id | doaj.art-2891e2b3a7d440a492aedb7729a57ab8 |
| institution | Directory Open Access Journal |
| issn | 2409-4943 2413-5003 |
| language | English |
| last_indexed | 2024-03-11T20:34:05Z |
| publishDate | 2013-04-01 |
| publisher | National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry |
| record_format | Article |
| series | The Ukrainian Biochemical Journal |
| spelling | doaj.art-2891e2b3a7d440a492aedb7729a57ab82023-10-02T07:19:17ZengNational Academy of Sciences of Ukraine, Palladin Institute of BiochemistryThe Ukrainian Biochemical Journal2409-49432413-50032013-04-01852334410.15407/ubj85.02.033Action of free and polymer carrier encapsulated doxorubicin towards HCT116 cells of human colorectal carcinomaYu. V. Senkiv0P. Heffeter1A. O. Riabtseva2N. M. Boiko3O. S. Zaichenko4N. Ye. Mitina5W. Berger6R. S. Stoika7Institute of Cell Biology, National Academy of Sciences of Ukraine, Lviv; Institute for Cancer Research, Medical University of Vienna, Austria; Ivan Franko Lviv National University, UkraineInstitute for Cancer Research, Medical University of Vienna, AustriaNational University Lviv Polytechnic, UkraineInstitute of Cell Biology, National Academy of Sciences of Ukraine, LvivNational University Lviv Polytechnic, UkraineNational University Lviv Polytechnic, UkraineInstitute for Cancer Research, Medical University of Vienna, AustriaInstitute of Cell Biology, National Academy of Sciences of Ukraine, LvivDevelopment of novel nanoscale functionalized carriers is nowadays one of the most urgent problems in cancer treatment. The aim of our study was to compare the antineoplastic effect of free doxorubicin and its complex with a nanoscale polymeric carrier towards HTC116 colorectal carcinoma cells. It was established that application of the complex of poly(5-tret-butylperoxy)-5-methyl-1-hexene-3-in-co-glycydyl metacrylat)-graft-polyethyleneglycol (poly(VEP-GMA-PEG)-graft-PEG), where VEP – 5-tret-butylperoxy)-5-methyl-1-hexene-3-in; GMA – glycydyl metacrylat; graft-PEG – graft-polyethyleneglycol accordingly, functionalized with phosphatidylcholine for doxorubicin delivery increased 10 times the efficiency of cytotoxic action of this drug, as compared wich such efficiency in case of the action of free doxorubicin. The encapsulated form of doxorubicin caused more intensive cleavage of the reparation enzyme PARP and longer delay in G2/M cell cycle arrest, compared to such effects of free doxorubicin. The developed carrier itself is non-toxic to the used mammalian cells and does not cause impairment in their cell cycle. A deletion in both alleles of p53 gene did not affect the antineoplastic action of doxorubicin that was immobilized on the nanoscale carrier. Thus, p53-dependent signaling pathways are not involved in the cytotoxic action of doxorubicin-carrier complex. It is suggested that novel nanoscale polymeric carrier poly(VEP-GMA-PEG)-graft-PEG functionalized with phosphatidylcholine could be a promising carrier for targeted delivery of anticancer drugs.http://ukrbiochemjournal.org/wp-content/uploads/2015/10/Senkiv_2_13.pdfapoptosiscell cycledoxorubicinhuman colorectal carcinoma cellsnanoscale polymeric drug carrierPARP |
| spellingShingle | Yu. V. Senkiv P. Heffeter A. O. Riabtseva N. M. Boiko O. S. Zaichenko N. Ye. Mitina W. Berger R. S. Stoika Action of free and polymer carrier encapsulated doxorubicin towards HCT116 cells of human colorectal carcinoma The Ukrainian Biochemical Journal apoptosis cell cycle doxorubicin human colorectal carcinoma cells nanoscale polymeric drug carrier PARP |
| title | Action of free and polymer carrier encapsulated doxorubicin towards HCT116 cells of human colorectal carcinoma |
| title_full | Action of free and polymer carrier encapsulated doxorubicin towards HCT116 cells of human colorectal carcinoma |
| title_fullStr | Action of free and polymer carrier encapsulated doxorubicin towards HCT116 cells of human colorectal carcinoma |
| title_full_unstemmed | Action of free and polymer carrier encapsulated doxorubicin towards HCT116 cells of human colorectal carcinoma |
| title_short | Action of free and polymer carrier encapsulated doxorubicin towards HCT116 cells of human colorectal carcinoma |
| title_sort | action of free and polymer carrier encapsulated doxorubicin towards hct116 cells of human colorectal carcinoma |
| topic | apoptosis cell cycle doxorubicin human colorectal carcinoma cells nanoscale polymeric drug carrier PARP |
| url | http://ukrbiochemjournal.org/wp-content/uploads/2015/10/Senkiv_2_13.pdf |
| work_keys_str_mv | AT yuvsenkiv actionoffreeandpolymercarrierencapsulateddoxorubicintowardshct116cellsofhumancolorectalcarcinoma AT pheffeter actionoffreeandpolymercarrierencapsulateddoxorubicintowardshct116cellsofhumancolorectalcarcinoma AT aoriabtseva actionoffreeandpolymercarrierencapsulateddoxorubicintowardshct116cellsofhumancolorectalcarcinoma AT nmboiko actionoffreeandpolymercarrierencapsulateddoxorubicintowardshct116cellsofhumancolorectalcarcinoma AT oszaichenko actionoffreeandpolymercarrierencapsulateddoxorubicintowardshct116cellsofhumancolorectalcarcinoma AT nyemitina actionoffreeandpolymercarrierencapsulateddoxorubicintowardshct116cellsofhumancolorectalcarcinoma AT wberger actionoffreeandpolymercarrierencapsulateddoxorubicintowardshct116cellsofhumancolorectalcarcinoma AT rsstoika actionoffreeandpolymercarrierencapsulateddoxorubicintowardshct116cellsofhumancolorectalcarcinoma |